LTGO 8-K 2026-11-05

Latigo Biotherapeutics, Inc. (LTGO) 8-K dated 2026-11-05 — accession 0001193125-26-448537.

Latigo Biotherapeutics, Inc. (LTGO) common stock.

Latigo Biotherapeutics, Inc. filed a 8-K on 2026-11-05. Accession 0001193125-26-448537.

This 8-K covers: Results of operations (Item 2.02), Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for LTGO is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The LTGO SEC hub lists recent forms. The stock page is the research view.